Winship urologist Vikram Narayan, MD, FACS, was profiled by Apple for Emory Healthcare's use of Apple technology to streamline workflows and enhance patient care. 🎥 Read more and Watch the video ➡️ brnw.ch/21wUcrF

Thanks to Zachary Klaassen for a great conversation on BCG unresponsive non-muscle invasive #bladdercancer —working through three common, real-world patient cases to think through practical considerations on sequencing and using these new therapies. www.urotoday.com/video-lectur...

#Quiz A 61-year-old woman presented with refractory hypercalcemia. She had obstructive uropathy secondary to bilateral ureteral stones. The stone composition was 80% calcium oxalate, 20% calcium phosphate. What was the etiology? bit.ly/Varanasi25Quiz (FREE)

Results of CREST: sasanlimab+BCG in BCG naive HR NMIBC patients offers a 32% risk reduction in HR recurrence, persistent CIS, progression, or death compared to BCG alone. www.nature.com/articles/s41... AEs are 🤨 - Grade 3 - 29%(!!) for sasanlimab pts vs 6% for BCG - 2 treatment related deaths

. @jackiebrownmd.bsky.social

Radiation oncologist Patricia Santos, MD, MS, @trishasantos.bsky.social shares insights on her poster highlighting “Access to cancer care for undocumented immigrants in the United States.” #ASCO25

My thanks to my #EmoryUrology family and the teams at #Apple and @hey.epic.com for helping us tell the @emoryhealthcareatl.bsky.social story of how clinician well-being is being prioritized through the use of great technology www.apple.com/healthcare/s...

Great spotlight of my friend and colleague @ssjoshi.bsky.social , highlighting the fantastic bladder cancer work the @winshipcancer.emory.edu and Emory Urology teams are doing to help our patients and their families @emoryuroonc.bsky.social winshipcancer.emory.edu/stories/arch...

Congratulations to our very own @tgoodstein.bsky.social for being awarded the 2025 Society of Urologic Oncology #CGOncology #NMIBC Fellowship Grant at #AUA2025 @ssjoshi.bsky.social @drnarayan.com

Congratulations to Sid Marthi @emoryuroonc.bsky.social for winning Best Poster at this morning’s Improving Access & Outcomes Across All Populations session at #AUA2025, highlighting the great collaboration between #GradyHealth, #MorehouseSM and #Emory to improve #ProstateCancer care inequities

Kudos to @amehtamd.bsky.social and colleagues for a fantastic session on vasectomy guidelines - key takeaways: fascial interposition, allow patient autonomy, and there’s no plausible biological link to prostate cancer #AUA2025

A good #AUA2025. Thank you for the invitation to present on the topic of APPs in leadership! #APPSession #Urology

Enjoying a sparks flying crossfire in treatment BCG unresponsive NMIBC, special shout out to my partner @ssjoshi.bsky.social and my friends Vig Packiam, Cheryl Lee, William Huang, and @tullikagarg.bsky.social at #AUA2025

My sincere thanks to Philipp Dahm, the University of #Minnesota Department of Urology, and the Minnesota #Urologic Society for the honor of a VP invitation—was great to see and spend time with old friends and mentors

Thanks again to Tommy Korn and everyone at Sharp Healthcare for hosting a fantastic Spatial Computing Health Care Summit - awesome to see all the amazing things people have been doing with Apple #VisionPro & to share some of what we’ve been able to do with our partners at #KarlStorz #SharpSpatial

“Grateful to be at #SWIU surrounded by incredible women—friends, colleagues, and mentees. Inspired by the exchange of ideas and learning about topics that truly empower us to lead fulfilled and successful lives. Here’s to growth, community, and innovation! 🩷 #WomenInUrology” @emoryuroonc.bsky.social

Looking forward to this! DM me if interested

Interested in learning about Emory’s #SUO fellowship? 📆 Join us for a virtual open house on Thursday, Jan 16th from 7-8 PM EST DM or email us if you’re interested -we’ll send you a link! @ssjoshi.bsky.social @valentinagrajales.bsky.social @tgoodstein.bsky.social @winshipatemory.bsky.social

This study suggests that a negative PSMA PET scan can help avoid unnecessary pelvic lymph node dissection in intermediate-risk prostate cancer patients, potentially reducing treatment complications without compromising outcomes. #ProstateCancer #MedicalImaging

always double glove

Surgeons showed significantly greater manual dexterity compared with physicians, nurses, and non-clinical staff when assessed using a buzz wire game. But had the highest rates of swearing www.bmj.com/content/387/...

Thx again to my friend @ddshapiro.bsky.social for giving us an outstanding Grand Rounds today @emoryuroonc.bsky.social & @winshipatemory.bsky.social on #RenalMedullaryCarcinoma. Inspiring work presented in an incredibly understandable & engaging way @msaouel.bsky.social @jackiebrownmd.bsky.social

Hello all. #urology #redsox #coys #golf #newyorkgiants

Happy to meet with anyone interested in the @SUO Fellowship @uthealthsa.bsky.social 🔬 Robust research opportunities 🎓 Master's Degree ✂️ High surgical volume in open and robotic approaches Send me a DM if interested #SUO24

and welcome to @bsky.app to @umbreit.bsky.social ! #SUO24

Proud of our first @emoryuroonc.bsky.social SUO fellow #TaylorGoodstein making a splash in RCC research at the #SUO24 Winter Meeting @ssjoshi.bsky.social @jackiebrownmd.bsky.social

(1/8) For those on Bluesky, I'm a uro onc @mdanderson.bsky.social specializing in prostate cancer, biomarkers, disparities, and behavioral interventions. We're taking a tour through classic obesity literature to help inform patient counseling and future studies.

Packed house at SUO2024 for NMIBC discussion. Our thought leader @drnarayan.com from @emoryuroonc.bsky.social @winshipatemory.bsky.social Ongoing challenge: how do we manage high risk NMIBC? Especially those with variants? @valentinagrajales.bsky.social

Proud of my friend @drnarayan.com giving great talk at #suo on cystectomy for NMIBC

What better time than #SUO24 to jump over to Bluesky! Thanks @chapinmd.bsky.social and @drnarayan.com for the nudge. Stay tuned, I'll be sure to keep the prostate cancer/obesity threads going over here.

Looking forward to #SUO24 in a few days And my friend @jackiebrownmd.bsky.social’s presentation on Emerging Perioperative Systemic Therapy for Urothelial Cancer at this year’s #BladderCancer course @winshipatemory.bsky.social @emoryuroonc.bsky.social

Happy #Thanksgiving to all of my wonderful friends and colleagues Switching over to #Claude by @anthropic.com today from #ChatGPT (we had a fight) and trying to convince myself I don’t need this puppy www.casio.com/us/watches/c...

Welcome to @bsky.app @valentinagrajales.bsky.social ! go.bsky.app/NwN3jSo

Urology residents of @bsky.app , let us know if you will be in Dallas for SUO 2024 and would like to chat about the @emoryuroonc.bsky.social SUO Fellowship! @drnarayan.com @valentinagrajales.bsky.social

Interesting study…only 56% OS at 5 years strikes me as lower than I would expect; by comparison an 80% 5 year OS was observed in the ph3 nado trial for BCG unresponsive pts (76% in CIS only patients, 86% in papillary dz). Worth calling out the 53% grade 3 AE rate as well… @emoryuroonc.bsky.social

Made this with @ddshapiro.bsky.social, reach out if we missed you! @mdanderson.bsky.social @chapinmd.bsky.social go.bsky.app/NwN3jSo

@emoryuroonc.bsky.social welcome to Bluesky!

Welcome to @bsky.app my friend @ddshapiro.bsky.social Time to get him added to the GU onc and kidney cancer starter packs!! bsky.app/start/did:pl...

My best travel tip is to quickly say "have a nice day" to the driver dropping you off so as to avoid spending the entire trip thinking about you said "you too" in response to "have a nice flight."

To echo @dr-coops.bsky.social i thought we could thread some of the most interesting #BladderCancer papers over the last few months ... that might have missed discussion @alisonbirtle.bsky.social @bladdercancer.bsky.social .....

'TrialGPT' A new chatGPT for clinical trials @natureportfolio.bsky.social: - 3 steps: TrialGPT-Retrieval, TrialGPT-Matching, TrialGPT-Ranking - Retrieval identified 90% suitable trials - 42% time-saving in matching a patient to a trial Like, wow #MedSky #OncSky #LCSM www.nature.com/articles/s41...

Saw a real person, on a real iPhone, on a real airplane, scrolling Bluesky. This thing really… took off!

Lots of ongoing questions re: how to “predict” responses to intravesical therapy, particularly for BCG unresponsive dz. Our study looked at UroAmp MRD in patients receiving nadofaragene -can prognosticate 12 mo RFS -can characterize utDNA over time euoncology.europeanurology.com/article/S258...

GU starter pack… started! Let me know if you want to be added. go.bsky.app/DtoXvaD #Genitourinary #Oncology #GUonc #ProstateCancer #KidneyCancer #Urothelial #BladderCancer #PenileCancer #TesticularCancer #pcsm #kcsm #blcsm #tcsm #Medsky #Medtwitter

Great day spent on strategic planning with AUA to improve Urology clinical trial participation at both patient and provider level. Stay tuned! @dr-coops.bsky.social

It’s all greek to me #athens

the irony of this graph not having an x-axis

Welp I guess this is better than X